Autolus Therapeutics PLC expected to post a loss of 51 cents a share - Earnings Preview

Autolus Therapeutics

01/11/2021 14:05

* Autolus Therapeutics PLC  AUTL.OQ   AUTL.O  is expected
to show a fall in quarterly revenue when it reports  results on
November 3. 
* The London, United Kingdom-based company is expected to report
 a 63.5% decrease in revenue to $248.33 thousand from $680
thousand a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Autolus Therapeutics
PLC is for a loss of 51 cents per share. For the same quarter
last year, the company reported a loss of 72 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $13​, about 57.1% above​ its last closing
price of $5.58. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.50       -0.50      -0.47     Beat    5.8
 Mar. 31 2021  -0.61       -0.60      -0.52     Beat    14
 Dec. 31 2020  -0.78       -0.77      -0.83     Missed  -8.4​
 Sep. 30 2020  -0.70       -0.71      -0.72     Missed  -1.9
 Jun.          -0.70​      -0.71      -0.62     Beat    12.5​
 30​ 2020​                                              
 Mar. 31 2020  -0.76       -0.74      -0.60     Beat    19.1​
 Dec. 31 2019  -0.72       -0.74      -0.84     Missed  -13.8
 Sep. 30 2019  -0.85       -0.84      -0.61     Beat    27.8
 This summary was machine generated November 1 at 14:05 GMT.  All
figures in US dollars unless otherwise stated